These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 16773200)

  • 41. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
    Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Decensi A; Bonanni B; Baglietto L; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Robertson C; Marinucci I; Mariette F; Sandri MT; Daldoss C; Bianco V; Buttarelli M; Cazzaniga M; Franchi D; Cassano E; Omodei U
    Clin Cancer Res; 2004 Jul; 10(13):4389-97. PubMed ID: 15240527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
    Kim HJ; Cui X; Hilsenbeck SG; Lee AV
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
    Bohlke K; Cramer DW; Trichopoulos D; Mantzoros CS
    Epidemiology; 1998 Sep; 9(5):570-3. PubMed ID: 9730040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women.
    Hofling M; Löfgren L; von Schoultz E; Carlström K; Söderqvist G
    Gynecol Endocrinol; 2008 Jul; 24(7):405-10. PubMed ID: 18645713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
    Rydén L; Landberg G; Stål O; Nordenskjöld B; Fernö M; Bendahl PO
    Breast Cancer Res Treat; 2008 May; 109(2):351-7. PubMed ID: 17636399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones.
    Tworoger SS; Missmer SA; Eliassen AH; Barbieri RL; Dowsett M; Hankinson SE
    Cancer Causes Control; 2007 Sep; 18(7):743-52. PubMed ID: 17549594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased Igf-I/Igfbp-3 Ratios in Postmenopausal Taiwanese with Breast Cancer, Irrespective of Er and Pr Statuses and Her2 Expression in a Case-Control Study.
    Lee SC; Tsai SM; Hou MF; Tien LY; Wu SH; Hou LA; Tsai JM; Tsai LY
    J Clin Lab Anal; 2016 Jan; 30(1):58-64. PubMed ID: 25385317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
    Zhang M; Yang H; Holman CD
    Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.
    Wu X; Tortolero-Luna G; Zhao H; Phatak D; Spitz MR; Follen M
    Clin Cancer Res; 2003 Aug; 9(9):3356-61. PubMed ID: 12960122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obesity and risk of the less commonly diagnosed subtypes of breast cancer.
    Stark A; Schultz D; Kapke A; Nadkarni P; Burke M; Linden M; Raju U
    Eur J Surg Oncol; 2009 Sep; 35(9):928-35. PubMed ID: 19121564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor-I, soy protein intake, and breast cancer risk.
    Sanderson M; Shu XO; Yu H; Dai Q; Malin AS; Gao YT; Zheng W
    Nutr Cancer; 2004; 50(1):8-15. PubMed ID: 15572292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
    Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID; Rinaldi S; Dossus L; Gils CH; Peeters PH; Noord PA; Bueno-de-Mesquita HB; Johnsen SP; Overvad K; Olsen A; Tjønneland A; Boeing H; Lahmann PH; Linseisen J; Nagel G; Allen N; Roddam A; Bingham S; Khaw KT; Kesse E; Téhard B; Clavel-Chapelon F; Agudo A; Ardanaz E; Quiros JR; Amiano P; Martínez-Garcia C; Tormo MJ; Pala V; Panico S; Vineis P; Palli D; Tumino R; Trichopoulou A; Baibas N; Zilis D; Hémon B; Norat T; Riboli E; Kaaks R
    Cancer Causes Control; 2005 Jun; 16(5):561-72. PubMed ID: 15986111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.
    Gunnell D; Miller LL; Rogers I; Holly JM;
    Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.